Validation pour Ingenuity080

vers la météo de la validation par utilisateur

Ingenuity080

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 79 - PMID ?

Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of SP NODE mRNA in Hela cells treated with agonist anti SP Apo 1 [NODE] protein antibody and overproducing SP NODE protein .

name="reponse" value="NA"> Non annotée
name="reponse" value="JSP"> Je ne sais pas
name="reponse" value="INS"> Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

<?php echo $Com ; ?>

name="reponse" value="A0">Analyse 0

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |                                +--------------COMP:N-N(in)-------------+      +---COMP:V_PASS-N(with)---+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A1">Analyse 1

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                          |              |                                +--------------COMP:N-N(in)-------------+      +---COMP:V_PASS-N(with)---+                                                          |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A2">Analyse 2

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                              +------COMP:V-N(with)-----+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A3">Analyse 3

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                                                        +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A4">Analyse 4

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+------COMP:V_PASS-N(with)-----+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A5">Analyse 5

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+------COMP:V-N(with)-----+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A6">Analyse 6

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+------COMP:V-N(with)-----+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A7">Analyse 7

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+------COMP:V-N(with)-----+                                                                  |             
                          |              |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A8">Analyse 8

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+------COMP:V-N(with)-----+                                                                  |             
                          |              |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A9">Analyse 9

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |                                +--------------COMP:N-N(in)-------------+      |                         +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A10">Analyse 10

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |                                |                                       |                                +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A11">Analyse 11

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------COMP:N-N(in)-------------+      +---COMP:V_PASS-N(with)---+                                                          |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A12">Analyse 12

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A13">Analyse 13

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |                                |                                       |      +---COMP:V_PASS-N(with)---+                                                                  |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A14">Analyse 14

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+                         +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A15">Analyse 15

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |                                +-----------COMP:N-N(in)-----------+           |                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A16">Analyse 16

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                                  |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A17">Analyse 17

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                                           +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A18">Analyse 18

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+--------COMP:V-N(with)--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A19">Analyse 19

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |                                +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A20">Analyse 20

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A21">Analyse 21

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                              +------------------------COMP:V-N(with)-----------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                              |                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A22">Analyse 22

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |                                +-----------COMP:N-N(in)-----------+           +------COMP:V-N(with)-----+                                                                  |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A23">Analyse 23

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------COMP:N-N(in)-------------+                                                                                           |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            +------------COMP:N-N(with)-----------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A24">Analyse 24

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A25">Analyse 25

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +--------------OBJ:V-N-------------+------COMP:V-N(with)-----+                                                                  |             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A26">Analyse 26

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |                                |                          |                   +---COMP:V_PASS-N(with)---+                                                          |                     
                          |              |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A27">Analyse 27

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A28">Analyse 28

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |                                +--------------COMP:N-N(in)-------------+      |            +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A29">Analyse 29

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                         +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A30">Analyse 30

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                          |              |             |                  +-------COMP:N-N(of)-------+                   +--------COMP:V-N(with)--------+                                                     |                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A31">Analyse 31

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                                                                        +----------------------COMP:V-N(with)----------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A32">Analyse 32

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |           +--------------OBJ:V-N-------------+                         +----------------------COMP:V-N(with)----------------------+                     
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A33">Analyse 33

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+------COMP:V-N(with)-----+                                                                  |             
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A34">Analyse 34

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------COMP:N-N(in)-------------+                                +--------------------------COMP:V-N(with)--------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A35">Analyse 35

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                         +----------------------COMP:V-N(with)----------------------+                     
                          |              |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                     |                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A36">Analyse 36

                                                                                                                         +-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         +----------------------------------COMP:V-N(in)---------------------------------+--------------------------OBJ:V-N-------------------------+                                         |     
                                         |                                +-----------------COMP:V-N(in)-----------------+------COMP:V-N(with)-----+                                |                                         |     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                           |              +-------MOD_ATT:N-ADJ------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       +COMP:V-N(in+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(in) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A37">Analyse 37

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                       +----------------------------------------------SUBJ:V-N---------------------------------------------+             
                          |              |                                |                                       |             +-----------------------------------OBJ:V-N-----------------------------------+       |             
                          |              |                                |                                       |             +----------------------OBJ:V-N----------------------+                         |       |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      +------COMP:V_PASS-N(with)-----+                           |                         |       |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                         |       |             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
OBJ:V-N (with,antibody)
OBJ:V-N (with,__SP__)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A38">Analyse 38

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+------COMP:V-N(with)-----+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A39">Analyse 39

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+------COMP:V-N(with)-----+                                                                  |             
                          |              |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A40">Analyse 40

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |                                |           +--------------OBJ:V-N-------------+                              |                                                             |             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                              |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A41">Analyse 41

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                              +------------------------COMP:V-N(with)-----------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A42">Analyse 42

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |                                             +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A43">Analyse 43

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A44">Analyse 44

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A45">Analyse 45

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                                           +---------------------------------COMP:V-N(with)--------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A46">Analyse 46

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A47">Analyse 47

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      +------COMP:V_PASS-N(with)-----+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A48">Analyse 48

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                                           +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A49">Analyse 49

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                         +----------------------COMP:V-N(with)----------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A50">Analyse 50

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+------COMP:V_PASS-N(with)-----+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A51">Analyse 51

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                              +------------------------COMP:V-N(with)-----------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A52">Analyse 52

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |                   +------COMP:V-N(with)-----+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+                          |                   |      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A53">Analyse 53

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                          |              |                                |           +--------------OBJ:V-N-------------+------COMP:V-N(with)-----+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A54">Analyse 54

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |                                |                          |                   +---COMP:V_PASS-N(with)---+                                                                  |             
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A55">Analyse 55

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +--------------COMP:N-N(in)-------------+      |                         +--------------------------COMP:V-N(with)--------------------------+             
                                         |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A56">Analyse 56

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |                                |                          |            |                                +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |            |             +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A57">Analyse 57

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+------------------COMP:N-N(with)------------------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
COMP:N-N(with) (mRNA,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A58">Analyse 58

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A59">Analyse 59

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------COMP:N-N(in)-------------+      +---COMP:V_PASS-N(with)---+                                                                  |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A60">Analyse 60

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A61">Analyse 61

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A62">Analyse 62

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +------------------COMP:N-N(with)------------------+                                                             |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
COMP:N-N(with) (mRNA,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A63">Analyse 63

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A64">Analyse 64

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------COMP:N-N(in)-------------+                   +---------------------------------COMP:V-N(with)--------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A65">Analyse 65

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |                                +-----------COMP:N-N(in)-----------+           |                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           +--------COMP:V-N(with)--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A66">Analyse 66

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                              |                                                             |             
                                         |                                +--------------COMP:N-N(in)-------------+      |                              |                                                             |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |                              |                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A67">Analyse 67

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                              |                                                             |             
                                         |                                +--------------COMP:N-N(in)-------------+      |                              |                                                             |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A68">Analyse 68

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                              |                                                             |             
                                         |                                +--------------COMP:N-N(in)-------------+      |                              |                                                             |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A69">Analyse 69

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   +--------COMP:V-N(with)--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A70">Analyse 70

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                                                                 +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A71">Analyse 71

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------COMP:N-N(in)-------------+                          +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                          |                                      +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A72">Analyse 72

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+            +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A73">Analyse 73

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |                                |                   +----------OBJ:V-N---------+                              |                                                             |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                              |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A74">Analyse 74

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                   +------COMP:V_PASS-N(with)-----+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A75">Analyse 75

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                              +------------------------COMP:V-N(with)-----------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A76">Analyse 76

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |                                             +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A77">Analyse 77

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A78">Analyse 78

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A79">Analyse 79

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                                           +---------------------------------COMP:V-N(with)--------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A80">Analyse 80

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A81">Analyse 81

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                                           +---------------------------------COMP:V-N(with)--------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A82">Analyse 82

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                   +----------OBJ:V-N---------+            +-----------------------------COMP:V-N(with)----------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A83">Analyse 83

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |                                +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A84">Analyse 84

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |                                |                          |                   +------COMP:V-N(with)-----+                                                          |                     
                          |              |       +-------MOD_ATT:N-N------+                          |                   |      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A85">Analyse 85

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                              +--------------------COMP:V-N(with)-------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,Apo)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A86">Analyse 86

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                                         |                                +--------------COMP:N-N(in)-------------+      |            +-----------------------------COMP:V-N(with)----------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A87">Analyse 87

                                         +----------------------------------COMP:V-N(in)---------------------------------+                                                                                                          
                                         |             +---------------------------COMP:V-N(in)--------------------------+                                                                                                          
                                         |             |                  +-------------------SUBJ:V-N-------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         |             |                  +--------------COMP:N-N(in)-------------+      +--------------------------OBJ:V-N-------------------------+                                         |     
                                         |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                           |              +-------MOD_ATT:N-ADJ------+     
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A88">Analyse 88

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                              |                                                             |             
                          |              |                                +--------------COMP:N-N(in)-------------+      |                              |                                                             |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |                              |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A89">Analyse 89

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                          |              |             |                  +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                          |              |             |                  +-------COMP:N-N(of)-------+            |      |                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A90">Analyse 90

                                         +----------------------------------COMP:V-N(in)---------------------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         |                                +-----------------COMP:V-N(in)-----------------+--------------------------OBJ:V-N-------------------------+                                         |     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   +--------COMP:V-N(with)--------+                           |              +-------MOD_ATT:N-ADJ------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A91">Analyse 91

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                                                              +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A92">Analyse 92

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A93">Analyse 93

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |                                +--------------COMP:N-N(in)-------------+                                     |                                                             |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                                     |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A94">Analyse 94

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |                                +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A95">Analyse 95

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          +------------------COMP:N-N(with)------------------+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
COMP:N-N(with) (mRNA,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A96">Analyse 96

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |                                |                                       |                   +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A97">Analyse 97

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A98">Analyse 98

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |                                +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A99">Analyse 99

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                       +----------------------------------------------SUBJ:V-N---------------------------------------------+             
                                         |                                |                                       |             +-----------------------------------OBJ:V-N-----------------------------------+       |             
                                         |                                |                                       |             +----------------------OBJ:V-N----------------------+                         |       |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      +------COMP:V_PASS-N(with)-----+                           |                         |       |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                         |       |             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
OBJ:V-N (with,antibody)
OBJ:V-N (with,__SP__)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A100">Analyse 100

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                       +----------------------------------------------SUBJ:V-N---------------------------------------------+             
                                         |                                |                                       |             +-----------------------------------OBJ:V-N-----------------------------------+       |             
                                         |                                |                                       |             +----------------------OBJ:V-N----------------------+                         |       |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      +------COMP:V_PASS-N(with)-----+                           |                         |       |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                         |       |             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
OBJ:V-N (with,antibody)
OBJ:V-N (with,__SP__)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A101">Analyse 101

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                   +----------OBJ:V-N---------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                                                                                    |                     
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A102">Analyse 102

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A103">Analyse 103

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |                                +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      +------COMP:V_PASS-N(with)-----+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A104">Analyse 104

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                          |              |                                +-----------COMP:N-N(in)-----------+           |                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |                                                                                    |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A105">Analyse 105

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A106">Analyse 106

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |                                +--------------COMP:N-N(in)-------------+      |                   +-----------------------------COMP:V-N(with)-----------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |                   |                                      +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A107">Analyse 107

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +-------COMP:N-N(of)-------+                   |                              +------------------------COMP:V-N(with)-----------------------+             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A108">Analyse 108

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                              +------------------------COMP:V-N(with)-----------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A109">Analyse 109

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                          +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A110">Analyse 110

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                              +------------------------COMP:V-N(with)-----------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A111">Analyse 111

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +--------------COMP:N-N(in)-------------+      |            +---------------------------------COMP:V-N(with)--------------------------------+             
                                         |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A112">Analyse 112

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                   +-------------------------COMP:V-N(with)-------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A113">Analyse 113

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                                       +----------------------------------------COMP:V-N(in)---------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(in) (__SP__,cell)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A114">Analyse 114

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                                         |             |                  +--------------COMP:N-N(in)-------------+      |                                                                                    |                     
                                         |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A115">Analyse 115

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                                                          +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A116">Analyse 116

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A117">Analyse 117

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                          |              |             |                  +-------COMP:N-N(of)-------+                   |                                                          +-------------SUBJ:V-N------------+             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A118">Analyse 118

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |                                +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A119">Analyse 119

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |            +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A120">Analyse 120

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |            +------------COMP:N-N(with)-----------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A121">Analyse 121

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                   |                                      +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A122">Analyse 122

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |                                +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |            +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A123">Analyse 123

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          +------------------COMP:N-N(with)------------------+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
COMP:N-N(with) (mRNA,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A124">Analyse 124

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A125">Analyse 125

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                                                  +------------------------COMP:V-N(with)-----------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A126">Analyse 126

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |                                +-----------COMP:N-N(in)-----------+           |                         +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A127">Analyse 127

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |                                             +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A128">Analyse 128

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |                                |                          |            |                   +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |            |             +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A129">Analyse 129

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A130">Analyse 130

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------COMP:N-N(in)-------------+                                                                                                   |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      +------COMP:V_PASS-N(with)-----+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A131">Analyse 131

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                                                                                            |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A132">Analyse 132

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                       +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A133">Analyse 133

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                          |              |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                     |                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A134">Analyse 134

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                                       +----------------------------------------COMP:V-N(in)---------------------------------------+                     
                          |              |                                |                                       |      +---COMP:V_PASS-N(with)---+                                                          |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(in) (__SP__,cell)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A135">Analyse 135

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------COMP:N-N(in)-------------+                          +-----------------------------COMP:V-N(with)-----------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                          |                                      +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A136">Analyse 136

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A137">Analyse 137

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+            +---------------------------------COMP:V-N(with)--------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A138">Analyse 138

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                          |              |                                +-----------COMP:N-N(in)-----------+           |                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |                   +-------------------------COMP:V-N(with)-------------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A139">Analyse 139

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |                                +--------------COMP:N-N(in)-------------+      |                         +--------------------------COMP:V-N(with)--------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A140">Analyse 140

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                                         |                                |                   +----------OBJ:V-N---------+------COMP:V-N(with)-----+                                                                  |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A141">Analyse 141

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                   +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+                     
                          |              |                                |                   +----------OBJ:V-N---------+                         +----------------------COMP:V-N(with)----------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__NODE__)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A142">Analyse 142

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                     |                     
                                         |                                |                   +----------OBJ:V-N---------+                              |                                                     |                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                              |                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A143">Analyse 143

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                   +-------------------------COMP:V-N(with)-------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A144">Analyse 144

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A145">Analyse 145

                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                                                                                                          
                          |              +----------------------------------COMP:V-N(in)---------------------------------+                                                                                                          
                          |              |                                +-----------------COMP:V-N(in)-----------------+                                                                                                          
                          |              |                                +-----------COMP:N-N(in)-----------+           +-----------------------------------------------OBJ:V-N----------------------------------------------+     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           +--------------------------OBJ:V-N-------------------------+              +-------MOD_ATT:N-ADJ------+     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(in) (treat,culture)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A146">Analyse 146

                                                                                                                                                   +----------------------------------OBJ:V-N---------------------------------+     
                                                                                                                                                   |       +----------------------------MOD_ATT:N-N---------------------------+     
                          +------------------------------------------------------COMP:V-N(in)------------------------------------------------------+       |      +------------------------MOD_ATT:N-N------------------------+     
                          |              +-----------------------------------------------COMP:V-N(in)----------------------------------------------+       |      |        +--------------------MOD_ATT:N-N-------------------+     
                          |              |                                +------------------------------COMP:V-N(in)------------------------------+       |      |        |        +---------------MOD_ATT:N-N---------------+     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            +----------COMP:V-N(in)----------+       |      |        |        |              +--------MOD_ATT:N-N-------+     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |                   +COMP:V-N(wit+       |      |        |        |              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +SUBJ:+       |      |        |        |              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |       |      |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(in) (__SP__,cell)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (protein,protein)
MOD_ATT:N-N (protein,antibody)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A147">Analyse 147

                                         +----------------------------------COMP:V-N(in)---------------------------------+                                                                                                          
                                         |                                +-----------------COMP:V-N(in)-----------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         |                                +-----------COMP:N-N(in)-----------+           +--------------------------OBJ:V-N-------------------------+                                         |     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |      +--------OBJ:V-N--------+                           |              +-------MOD_ATT:N-ADJ------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A148">Analyse 148

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                                                                                                |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A149">Analyse 149

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------COMP:N-N(in)-------------+                                                                                           |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                                                                                           |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A150">Analyse 150

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                                  |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A151">Analyse 151

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                              |                                                             |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A152">Analyse 152

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |                                +-----------COMP:N-N(in)-----------+           |                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A153">Analyse 153

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |                                +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A154">Analyse 154

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                                         |             |                  +-------COMP:N-N(of)-------+            |      +--------COMP:V-N(with)--------+                                                             |             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A155">Analyse 155

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                          |              |             |                  +-------COMP:N-N(of)-------+                   |                              +------------------------COMP:V-N(with)-----------------------+             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A156">Analyse 156

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                          |              |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A157">Analyse 157

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                          +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A158">Analyse 158

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |                                +--------------------OBJ:V-N-------------------+                              |                                                             |             
                          |              |                                +-----------COMP:N-N(in)-----------+           |                              |                                                             |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |                              |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A159">Analyse 159

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |                                |                          |            |      +---COMP:V_PASS-N(with)---+                                                                  |             
                                         |       +-------MOD_ATT:N-N------+                          |            |      |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A160">Analyse 160

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   +------COMP:V_PASS-N(with)-----+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A161">Analyse 161

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+------COMP:V_PASS-N(with)-----+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A162">Analyse 162

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------COMP:N-N(in)-------------+                          +-----------------------------COMP:V-N(with)-----------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                          |                                      +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A163">Analyse 163

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A164">Analyse 164

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |                                +-----------COMP:N-N(in)-----------+           |                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A165">Analyse 165

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                   +---------------------------------COMP:V-N(with)--------------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A166">Analyse 166

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          +------------------COMP:N-N(with)------------------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
COMP:N-N(with) (mRNA,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A167">Analyse 167

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------COMP:N-N(in)-------------+                                                                                           |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                          +-------------------------COMP:V-N(with)-------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A168">Analyse 168

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                                           +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A169">Analyse 169

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                          |              |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A170">Analyse 170

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |           +--------------------------COMP:N-N(with)-------------------------+                                                             |             
                          |              |                                |           +--------------OBJ:V-N-------------+                              |                                                             |             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                              |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(with) (__SP__,Apo)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A171">Analyse 171

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A172">Analyse 172

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |                                +--------------------OBJ:V-N-------------------+                              |                                                             |             
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                              |                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A173">Analyse 173

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |                                +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A174">Analyse 174

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+------COMP:V-N(with)-----+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A175">Analyse 175

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+------COMP:V-N(with)-----+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A176">Analyse 176

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                          |              |                                |           +--------------OBJ:V-N-------------+------COMP:V-N(with)-----+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A177">Analyse 177

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                          |              |             |                  +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                          |              |             |                  +-------COMP:N-N(of)-------+            |      |                              +------------------------COMP:V-N(with)-----------------------+             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A178">Analyse 178

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                          |              |                                |           +--------------OBJ:V-N-------------+            +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A179">Analyse 179

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                   +----------OBJ:V-N---------+------COMP:V-N(with)-----+                                                          |                     
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A180">Analyse 180

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------COMP:N-N(in)-------------+                                                                                                   |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            +------------COMP:N-N(with)-----------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A181">Analyse 181

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |           +--------------OBJ:V-N-------------+------COMP:V-N(with)-----+                                                          |                     
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A182">Analyse 182

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A183">Analyse 183

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A184">Analyse 184

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                              +------------------------COMP:V-N(with)-----------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A185">Analyse 185

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A186">Analyse 186

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A187">Analyse 187

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                          |              |             |                  +-------COMP:N-N(of)-------+                   |            +-----------------------------COMP:V-N(with)----------------------------+                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A188">Analyse 188

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                          |              |             |                  +--------------COMP:N-N(in)-------------+      +------COMP:V-N(with)-----+                                                          |                     
                          |              |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A189">Analyse 189

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A190">Analyse 190

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                          |              |                                +--------------COMP:N-N(in)-------------+      |                         +----------------------COMP:V-N(with)----------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A191">Analyse 191

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |                                |                          |                                                  +------------------------COMP:V-N(with)-----------------------+             
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+                              |                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A192">Analyse 192

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |            +------------COMP:N-N(with)-----------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A193">Analyse 193

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |            +------------COMP:N-N(with)-----------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A194">Analyse 194

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                   +----------OBJ:V-N---------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A195">Analyse 195

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                                                                                    |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A196">Analyse 196

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |                                |                          +------------------COMP:N-N(with)------------------+                                                     |                     
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+                              |                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
COMP:N-N(with) (mRNA,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A197">Analyse 197

                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                          |              +----------------------------------COMP:V-N(in)---------------------------------+--------------------------OBJ:V-N-------------------------+                                         |     
                          |              |                                +-----------------COMP:V-N(in)-----------------+------COMP:V-N(with)-----+                                |                                         |     
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                           |              +--------MOD_ATT:N-N-------+     
                          |              |       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,culture)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A198">Analyse 198

                                         +----------------------------------COMP:V-N(in)---------------------------------+                                                                                                          
                                         |                                +-----------------COMP:V-N(in)-----------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         |                                |                   +-------COMP:V-N(of)-------+--------------------------OBJ:V-N-------------------------+                                         |     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                           |              +-------MOD_ATT:N-ADJ------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(of) (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A199">Analyse 199

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                                                                                            |             
                          |              |       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A200">Analyse 200

                                                                                                                                                   +----------------------------------OBJ:V-N---------------------------------+     
                                                                                                                                                   |       +----------------------------MOD_ATT:N-N---------------------------+     
                                         +-----------------------------------------------COMP:V-N(in)----------------------------------------------+       |      +------------------------MOD_ATT:N-N------------------------+     
                                         |                                +------------------------------COMP:V-N(in)------------------------------+       |      |        +--------------------MOD_ATT:N-N-------------------+     
                                         |                                +--------------------OBJ:V-N-------------------+                         |       |      |        |        +---------------MOD_ATT:N-N---------------+     
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                         |       |      |        |        |              +--------MOD_ATT:N-N-------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |                         |       |      |        |        |              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +MOD:V-+     +MOD_AT+SUBJ:+       |      |        |        |              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |       |      |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
MOD:V-ADV (treat,with)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (protein,protein)
MOD_ATT:N-N (protein,antibody)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A201">Analyse 201

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |                                +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A202">Analyse 202

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A203">Analyse 203

                                         +----------------------------------COMP:V-N(in)---------------------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         |                                +-----------------COMP:V-N(in)-----------------+--------------------------OBJ:V-N-------------------------+                                         |     
                                         |       +-------MOD_ATT:N-N------+                          +----COMP:V-N(of)---+      +--------OBJ:V-N--------+                           |              +-------MOD_ATT:N-ADJ------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       +COMP:V-N(in+      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(of) (treat,mRNA)
COMP:V-N(in) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A204">Analyse 204

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A205">Analyse 205

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A206">Analyse 206

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                          |              |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A207">Analyse 207

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                          |              |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A208">Analyse 208

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                                         |                                |                   +----------OBJ:V-N---------+                              |                                                             |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A209">Analyse 209

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                                                                                            |             
                          |              |       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A210">Analyse 210

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                          |              |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+--------COMP:V-N(with)--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A211">Analyse 211

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A212">Analyse 212

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |                                       +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                                       |                                      +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A213">Analyse 213

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |                                +-----------COMP:N-N(in)-----------+           |            +---------------------------------COMP:V-N(with)--------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A214">Analyse 214

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A215">Analyse 215

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A216">Analyse 216

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +------------------COMP:N-N(with)------------------+                                                     |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                              |                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
COMP:N-N(with) (mRNA,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A217">Analyse 217

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                     |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                              |                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A218">Analyse 218

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                                         |                                +--------------COMP:N-N(in)-------------+      |                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |                                                                                    |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A219">Analyse 219

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                                                                        +----------------------COMP:V-N(with)----------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A220">Analyse 220

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A221">Analyse 221

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                                                                        +----------------------COMP:V-N(with)----------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A222">Analyse 222

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A223">Analyse 223

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------COMP:N-N(in)-------------+                                                                                                   |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                          +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A224">Analyse 224

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |           +--------------OBJ:V-N-------------+            +-----------------------------COMP:V-N(with)----------------------------+                     
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A225">Analyse 225

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |            +---------------------------------COMP:V-N(with)--------------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A226">Analyse 226

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A227">Analyse 227

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                                         |             |                  +-------COMP:N-N(of)-------+            |      |                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A228">Analyse 228

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |                                |                          |                                             +--------------------------COMP:V-N(with)--------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A229">Analyse 229

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   +------COMP:V_PASS-N(with)-----+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A230">Analyse 230

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------COMP:N-N(in)-------------+                                                                                           |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      +------COMP:V_PASS-N(with)-----+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A231">Analyse 231

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                                         |                                +--------------COMP:N-N(in)-------------+      |                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      +------COMP:V_PASS-N(with)-----+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A232">Analyse 232

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                                         |             |                  +--------------COMP:N-N(in)-------------+      +------COMP:V-N(with)-----+                                                          |                     
                                         |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A233">Analyse 233

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |           +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+                     
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A234">Analyse 234

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                     |                     
                                         |                                +--------------------OBJ:V-N-------------------+                              |                                                     |                     
                                         |                                +-----------COMP:N-N(in)-----------+           |                              |                                                     |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |                              |                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A235">Analyse 235

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A236">Analyse 236

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------COMP:N-N(in)-------------+                                                                                                   |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                          +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A237">Analyse 237

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A238">Analyse 238

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A239">Analyse 239

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |                                |                          |            |                          +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |            |                          |                                      +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A240">Analyse 240

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |            |                          +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A241">Analyse 241

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +------------------COMP:N-N(with)------------------+                                                     |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                              |                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
COMP:N-N(with) (mRNA,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A242">Analyse 242

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------COMP:N-N(in)-------------+                                                                                                   |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A243">Analyse 243

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A244">Analyse 244

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                              +--------------------COMP:V-N(with)-------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,Apo)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A245">Analyse 245

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+            +---------------------------------COMP:V-N(with)--------------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A246">Analyse 246

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A247">Analyse 247

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                                       +----------------------------------------COMP:V-N(in)---------------------------------------+                     
                          |              |                                |                                       |                   +-----------------------------COMP:V-N(with)----------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(in) (__SP__,cell)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A248">Analyse 248

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A249">Analyse 249

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +-------COMP:N-N(of)-------+                   |                              +------------------------COMP:V-N(with)-----------------------+             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A250">Analyse 250

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+            +---------------------------------COMP:V-N(with)--------------------------------+             
                                         |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A251">Analyse 251

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                                         |             |                  +-------COMP:N-N(of)-------+            |      |            +---------------------------------COMP:V-N(with)--------------------------------+             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A252">Analyse 252

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                                              +------COMP:V-N(with)-----+                                                          |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A253">Analyse 253

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                   +----------OBJ:V-N---------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+            +-----------------------------COMP:V-N(with)----------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A254">Analyse 254

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                                         |                                +--------------COMP:N-N(in)-------------+      |                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A255">Analyse 255

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                         +----------------------COMP:V-N(with)----------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A256">Analyse 256

                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                                                                                                          
                          |              +----------------------------------COMP:V-N(in)---------------------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                          |              |                                +-----------------COMP:V-N(in)-----------------+--------------------------OBJ:V-N-------------------------+                                         |     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   +--------COMP:V-N(with)--------+                           |              +--------MOD_ATT:N-N-------+     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       +COMP:V-N(in+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(in) (treat,culture)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(in) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A257">Analyse 257

                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                                                                                                          
                          |              +----------------------------------COMP:V-N(in)---------------------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                          |              |                                +-----------------COMP:V-N(in)-----------------+--------------------------OBJ:V-N-------------------------+                                         |     
                          |              |       +-------MOD_ATT:N-N------+                          +----COMP:V-N(of)---+      +--------OBJ:V-N--------+                           |              +-------MOD_ATT:N-ADJ------+     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       +COMP:V-N(in+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(in) (treat,culture)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(of) (treat,mRNA)
COMP:V-N(in) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A258">Analyse 258

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A259">Analyse 259

                                         +----------------------------------COMP:V-N(in)---------------------------------+                                                                                                          
                                         |             +---------------------------COMP:V-N(in)--------------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         |             |                  +-------------------SUBJ:V-N-------------------+--------------------------OBJ:V-N-------------------------+                                         |     
                                         |             |                  +--------------COMP:N-N(in)-------------+      +------COMP:V-N(with)-----+                                |                                         |     
                                         |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                           |              +--------MOD_ATT:N-N-------+     
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A260">Analyse 260

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+                                                                                            |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A261">Analyse 261

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                                         |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A262">Analyse 262

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                          |              |             |                  +-------COMP:N-N(of)-------+                   |            +-----------------------------COMP:V-N(with)----------------------------+                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A263">Analyse 263

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A264">Analyse 264

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |                                +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |            +---------------------------------COMP:V-N(with)--------------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A265">Analyse 265

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                   +---------------------------------COMP:V-N(with)--------------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A266">Analyse 266

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A267">Analyse 267

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |                                +--------------------OBJ:V-N-------------------+                              |                                                             |             
                          |              |                                +-----------COMP:N-N(in)-----------+           |                              |                                                             |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |                              |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A268">Analyse 268

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |                                +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A269">Analyse 269

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                          |                                                  +--------------------COMP:V-N(with)-------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
COMP:V-N(with) (__SP__,Apo)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A270">Analyse 270

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                                  +------------------------------------------COMP:V-N(in)------------------------------------------+                     
                          |              |                                |                                  |    +------------------------------------------SUBJ:V-N-----------------------------------------+                     
                          |              |                                |                                  |    |             +------------------------------OBJ:V-N-----------------------------+          |                     
                          |              |                                |                                  |    |             +----------------------OBJ:V-N----------------------+              |          |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |    |      +------COMP:V_PASS-N(with)-----+                           |              |          |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |    |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              |          +----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
OBJ:V-N (with,antibody)
OBJ:V-N (with,overproduce)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(in) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A271">Analyse 271

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------COMP:N-N(in)-------------+                                                                                           |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                                                                                           |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A272">Analyse 272

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------COMP:N-N(in)-------------+                                                                                           |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                          +-------------------------COMP:V-N(with)-------------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A273">Analyse 273

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                   +----------OBJ:V-N---------+            +-----------------------------COMP:V-N(with)----------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A274">Analyse 274

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                   +-------------------------COMP:V-N(with)-------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A275">Analyse 275

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                                         |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A276">Analyse 276

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A277">Analyse 277

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                          |              |             |                  +-------COMP:N-N(of)-------+                   |                              +--------------------COMP:V-N(with)-------------------+                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(with) (__SP__,Apo)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A278">Analyse 278

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                                         |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                                                          +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A279">Analyse 279

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                          |              |             |                  +--------------COMP:N-N(in)-------------+      |            +-----------------------------COMP:V-N(with)----------------------------+                     
                          |              |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+            |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A280">Analyse 280

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+--------COMP:V-N(with)--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A281">Analyse 281

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |                                |                          |                                             +----------------------COMP:V-N(with)----------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A282">Analyse 282

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |           +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+                     
                          |              |                                |           +--------------OBJ:V-N-------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+            +-----------------------------COMP:V-N(with)----------------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__SP__)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A283">Analyse 283

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |                                |                          |                                       +-----------------------------COMP:V-N(with)-----------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+                   |                                      +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A284">Analyse 284

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                                         |                                |                   +----------OBJ:V-N---------+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                   |                                      +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A285">Analyse 285

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                                         |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A286">Analyse 286

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A287">Analyse 287

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------COMP:N-N(in)-------------+                                                                                           |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            +------------COMP:N-N(with)-----------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A288">Analyse 288

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                   +----------OBJ:V-N---------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A289">Analyse 289

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                   +----------OBJ:V-N---------+                         +----------------------COMP:V-N(with)----------------------+                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A290">Analyse 290

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                                         |             |                  +--------------COMP:N-N(in)-------------+      |                                                                                    |                     
                                         |             |                  +-------COMP:N-N(of)-------+            |      +--------COMP:V-N(with)--------+                                                     |                     
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A291">Analyse 291

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |                                +--------------------OBJ:V-N-------------------+                              |                                                             |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                              |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A292">Analyse 292

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |                                +-----------COMP:N-N(in)-----------+           |                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A293">Analyse 293

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |                                +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A294">Analyse 294

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |            |             +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A295">Analyse 295

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |           +--------------OBJ:V-N-------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A296">Analyse 296

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A297">Analyse 297

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+            +---------------------------------COMP:V-N(with)--------------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A298">Analyse 298

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                     |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                                  |                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A299">Analyse 299

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A300">Analyse 300

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |            +------------COMP:N-N(with)-----------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A301">Analyse 301

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |                   +--------COMP:V-N(with)--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A302">Analyse 302

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |                                       +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A303">Analyse 303

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            +------------COMP:N-N(with)-----------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A304">Analyse 304

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A305">Analyse 305

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                                         |                                +-----------COMP:N-N(in)-----------+           |                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A306">Analyse 306

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+                   +-------------------------COMP:V-N(with)-------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A307">Analyse 307

                                         +----------------------------------COMP:V-N(in)---------------------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         |                                +-----------------COMP:V-N(in)-----------------+--------------------------OBJ:V-N-------------------------+                                         |     
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                           |              +--------MOD_ATT:N-N-------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A308">Analyse 308

                                                                                                                                                   +----------------------------------OBJ:V-N---------------------------------+     
                                                                                                                                                   |       +----------------------------MOD_ATT:N-N---------------------------+     
                                                                                                                                                   |       |      +------------------------MOD_ATT:N-N------------------------+     
                                         +-----------------------------------------------COMP:V-N(in)----------------------------------------------+       |      |        +--------------------MOD_ATT:N-N-------------------+     
                                         |                                +------------------------------COMP:V-N(in)------------------------------+       |      |        |        +---------------MOD_ATT:N-N---------------+     
                                         |       +-------MOD_ATT:N-N------+                          +-----------------COMP:V-N(of)----------------+       |      |        |        |              +--------MOD_ATT:N-N-------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+                         |       |      |        |        |              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+       |      |        |        |              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |       |      |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (protein,protein)
MOD_ATT:N-N (protein,antibody)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A309">Analyse 309

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |            |                   +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A310">Analyse 310

                                         +----------------------------------COMP:V-N(in)---------------------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         |                                +-----------------COMP:V-N(in)-----------------+--------------------------OBJ:V-N-------------------------+                                         |     
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                           |              +--------MOD_ATT:N-N-------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A311">Analyse 311

                                         +----------------------------------COMP:V-N(in)---------------------------------+      +-------------------------------------------OBJ:V-N-------------------------------------------+     
                                         |                                +-----------------COMP:V-N(in)-----------------+      +----------------------OBJ:V-N----------------------+                                         |     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   +--------COMP:V-N(with)--------+                           |              +--------MOD_ATT:N-N-------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       +COMP:V-N(in+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(in) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
OBJ:V-N (with,antibody)
OBJ:V-N (with,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A312">Analyse 312

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                          |              |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A313">Analyse 313

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                                         |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                              +------------------------COMP:V-N(with)-----------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A314">Analyse 314

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |            |                          +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A315">Analyse 315

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A316">Analyse 316

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                       +-------------------------COMP:V-N(with)-------------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A317">Analyse 317

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +--------------------------COMP:N-N(with)-------------------------+                                                             |             
                                         |                                |           +--------------OBJ:V-N-------------+                              |                                                             |             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(with) (__SP__,Apo)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A318">Analyse 318

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                       +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A319">Analyse 319

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                   +-------------------------COMP:V-N(with)-------------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A320">Analyse 320

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                                         |                                +--------------------OBJ:V-N-------------------+                              |                                                             |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A321">Analyse 321

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                                         |                                |           +--------------OBJ:V-N-------------+            +---------------------------------COMP:V-N(with)--------------------------------+             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A322">Analyse 322

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A323">Analyse 323

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                     |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                                  |                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A324">Analyse 324

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                              +--------------------COMP:V-N(with)-------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,Apo)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A325">Analyse 325

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+------COMP:V_PASS-N(with)-----+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A326">Analyse 326

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                              +--------------------COMP:V-N(with)-------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,Apo)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A327">Analyse 327

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                   +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+                     
                                         |                                |                   +----------------------COMP:N-N(with)---------------------+                                                     |                     
                                         |                                |                   +----------OBJ:V-N---------+                              |                                                     |                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                              |                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(with) (__NODE__,Apo)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__NODE__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A328">Analyse 328

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                                                                                            |             
                          |              |       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A329">Analyse 329

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A330">Analyse 330

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                                                                                    |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A331">Analyse 331

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                          |              |             |                  +-------COMP:N-N(of)-------+                   |                   +-------------------------COMP:V-N(with)-------------------------+                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A332">Analyse 332

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                   +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+                     
                          |              |                                |                   +----------OBJ:V-N---------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__NODE__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A333">Analyse 333

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |            |             +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A334">Analyse 334

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |                                |                          |            +----------------------------------------COMP:V-N(in)---------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                          |            |                                     +--------------------COMP:V-N(with)-------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
COMP:V-N(in) (__SP__,cell)
COMP:V-N(with) (__SP__,Apo)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A335">Analyse 335

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                                       +----------------------------------------COMP:V-N(in)---------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(in) (__SP__,cell)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A336">Analyse 336

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                                                           +-----------------------------COMP:V-N(with)----------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A337">Analyse 337

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                     |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                                  |                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A338">Analyse 338

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |                                |                          |                   +------COMP:V-N(with)-----+                                                          |                     
                                         |       +-------MOD_ATT:N-N------+                          |                   |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A339">Analyse 339

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |           +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+                     
                                         |                                |           +--------------OBJ:V-N-------------+------COMP:V-N(with)-----+                                                          |                     
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A340">Analyse 340

                                                                                                                         +-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                                                                                                         +--------------------------OBJ:V-N-------------------------+                                         |     
                                         +----------------------------------COMP:V-N(in)---------------------------------+------COMP:V-N(with)-----+                                |                                         |     
                                         |       +-------MOD_ATT:N-N------+-----------------COMP:V-N(in)-----------------+      +--------OBJ:V-N--------+                           |              +--------MOD_ATT:N-N-------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+----COMP:V-N(of)---+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(of) (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A341">Analyse 341

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                                       +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A342">Analyse 342

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A343">Analyse 343

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                          |              |                                +-----------COMP:N-N(in)-----------+           |                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |            +-----------------------------COMP:V-N(with)----------------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A344">Analyse 344

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+                   +-------------------------COMP:V-N(with)-------------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A345">Analyse 345

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                   +----------OBJ:V-N---------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                   +-------------------------COMP:V-N(with)-------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A346">Analyse 346

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                   +-------------------------COMP:V-N(with)-------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A347">Analyse 347

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+                          |            +------------COMP:N-N(with)-----------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A348">Analyse 348

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                                         |                                +--------------COMP:N-N(in)-------------+      |                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |            +-----------------------------COMP:V-N(with)----------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A349">Analyse 349

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                                +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A350">Analyse 350

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A351">Analyse 351

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                          |              |             |                  +-------COMP:N-N(of)-------+                   |                   +-------------------------COMP:V-N(with)-------------------------+                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A352">Analyse 352

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |           +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+                     
                          |              |                                |           +--------------OBJ:V-N-------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A353">Analyse 353

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |           +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+                     
                          |              |                                |           +--------------OBJ:V-N-------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A354">Analyse 354

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                          |                                       +-------------------------COMP:V-N(with)-------------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A355">Analyse 355

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                          |              |                                +-----------COMP:N-N(in)-----------+           |                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |            +-----------------------------COMP:V-N(with)----------------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A356">Analyse 356

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+            +---------------------------------COMP:V-N(with)--------------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A357">Analyse 357

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                   +----------OBJ:V-N---------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A358">Analyse 358

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |                                |                          +------------------COMP:N-N(with)------------------+                                                     |                     
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+                              |                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
COMP:N-N(with) (mRNA,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A359">Analyse 359

                                         +----------------------------------COMP:V-N(in)---------------------------------+                                                                                                          
                                         |                                +-----------------COMP:V-N(in)-----------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   +--------------------------OBJ:V-N-------------------------+              +--------MOD_ATT:N-N-------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A360">Analyse 360

                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                                                                                                          
                          |              +----------------------------------COMP:V-N(in)---------------------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                          |              |                                +-----------------COMP:V-N(in)-----------------+--------------------------OBJ:V-N-------------------------+                                         |     
                          |              |       +-------MOD_ATT:N-N------+                          +----COMP:V-N(of)---+      +--------OBJ:V-N--------+                           |              +--------MOD_ATT:N-N-------+     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       +COMP:V-N(in+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(in) (treat,culture)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(of) (treat,mRNA)
COMP:V-N(in) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A361">Analyse 361

                                         +----------------------------------COMP:V-N(in)---------------------------------+                                                                                                          
                                         |                                +-----------------COMP:V-N(in)-----------------+      +-------------------------------------------OBJ:V-N-------------------------------------------+     
                                         |                                |                   +-------COMP:V-N(of)-------+      +----------------------OBJ:V-N----------------------+                                         |     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+--------COMP:V-N(with)--------+                           |              +--------MOD_ATT:N-N-------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(of) (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,Apo)
OBJ:V-N (with,antibody)
OBJ:V-N (with,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A362">Analyse 362

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |                                +---------------------------------COMP:V-N(with)--------------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A363">Analyse 363

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A364">Analyse 364

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                     |                     
                                         |                                +--------------------OBJ:V-N-------------------+                              |                                                     |                     
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                              |                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A365">Analyse 365

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                                         |                                |                   +----------------------COMP:N-N(with)---------------------+                                                             |             
                                         |                                |                   +----------OBJ:V-N---------+                              |                                                             |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(with) (__NODE__,Apo)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A366">Analyse 366

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                                         |                                |                   +----------------------COMP:N-N(with)---------------------+                                                             |             
                                         |                                |                   +----------OBJ:V-N---------+                              |                                                             |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(with) (__NODE__,Apo)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

name="reponse" value="A367">Analyse 367

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                +-----------------------------COMP:V-N(with)----------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A368">Analyse 368

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                       +-------------------------COMP:V-N(with)-------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A369">Analyse 369

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |                                |                          |            +----------------------------------------COMP:V-N(in)---------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+                          |            |             +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
COMP:V-N(in) (__SP__,cell)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A370">Analyse 370

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                   +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+                     
                                         |                                |                   +----------OBJ:V-N---------+            +-----------------------------COMP:V-N(with)----------------------------+                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__NODE__)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A371">Analyse 371

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                   +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+                     
                                         |                                |                   +----------OBJ:V-N---------+            +-----------------------------COMP:V-N(with)----------------------------+                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__NODE__)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A372">Analyse 372

                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                                                                                                          
                          |              +----------------------------------COMP:V-N(in)---------------------------------+                                                                                                          
                          |              |                                +-----------------COMP:V-N(in)-----------------+                                                                                                          
                          |              |                                |           +-----------COMP:V-N(of)-----------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+--------------------------OBJ:V-N-------------------------+              +--------MOD_ATT:N-N-------+     
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,culture)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(of) (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A373">Analyse 373

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |           +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+                     
                          |              |                                |           +--------------------------COMP:N-N(with)-------------------------+                                                     |                     
                          |              |                                |           +--------------OBJ:V-N-------------+                              |                                                     |                     
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                              |                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(with) (__SP__,Apo)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A374">Analyse 374

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+                   +-------------------------COMP:V-N(with)-------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A375">Analyse 375

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |                                |                          |            +----------------------------------------COMP:V-N(in)---------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+                          |            |                   +-----------------------------COMP:V-N(with)----------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
COMP:V-N(in) (__SP__,cell)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

name="reponse" value="A376">Analyse 376

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |           +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+                     
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                                                                                    |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)